PNC Financial Services Group
CRMD icon

PNC Financial Services Group’s CorMedix CRMD Stock Holding History

PNC Financial Services Group’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.1K Buy
1,544
+324
+27% +$2.56K ﹤0.01% 4003
2026
Q1 		$8.28K Sell
1,220
-14
-1% -$103 ﹤0.01% 4034
2025
Q4 		$14.4K Sell
1,234
-779
-39% -$8.61K ﹤0.01% 3811
2025
Q3 		$23.4K Sell
2,013
-60
-3% -$725 ﹤0.01% 3564
2025
Q2 		$25.5K Sell
2,073
-116
-5% -$1.28K ﹤0.01% 3448
2025
Q1 		$13.5K Buy
2,189
+576
+36% +$5.96K ﹤0.01% 3714
2024
Q4 		$13.1K Sell
1,613
-3
-0.2% -$30 ﹤0.01% 3705
2024
Q3 		$13.1K Buy
1,616
+1,208
+296% +$6.54K ﹤0.01% 3700
2024
Q2 		$1.77K Hold
408
– – ﹤0.01% 4281
2024
Q1 		$1.73K Buy
408
+390
+2,167% +$1.35K ﹤0.01% 4238
2023
Q4 		$68 Buy
+18
New +$62 ﹤0.01% 4540

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

PNC Financial Services Group's CRMD Position: Q2 2026 in Review

PNC Financial Services Group increased its CorMedix (CRMD) stake by 27% in Q2 2026, buying an estimated $2.56K and bringing the position to 1,544 shares worth $12.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4003.

PNC Financial Services Group first reported a position in CRMD in Q4 2023 and has held it in 11 quarters since. The position peaked at $25.5K in Q2 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • PNC Financial Services Group held 1,544 shares of CorMedix worth $12.1K as of Q2 2026.
  • PNC Financial Services Group bought 324 CorMedix shares in Q2 2026, an estimated $2.56K.
  • CorMedix made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4003 holding.
  • PNC Financial Services Group first reported a position in CorMedix in Q4 2023 and has held it in 11 quarters since.
  • PNC Financial Services Group's CorMedix position peaked at $25.5K in Q2 2025.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.